Stuart Poulton - 15 Feb 2024 Form 4 Insider Report for Karyopharm Therapeutics Inc. (KPTI)

Signature
Nancy Smith as Attorney-in-Fact for Stuart Poulton
Issuer symbol
KPTI
Transactions as of
15 Feb 2024
Net transactions value
-$7,783
Form type
4
Filing time
20 Feb 2024, 16:59:03 UTC
Previous filing
25 Jan 2024
Next filing
29 Feb 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KPTI Common Stock Sale $7,645 -5,748 -3.4% $1.33 163,871 15 Feb 2024 Direct F1
transaction KPTI Common Stock Sale $139 -99 -0.06% $1.40 163,772 15 Feb 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a durable automatic sale instruction plan adopted by the reporting person on May 18, 2022, and represents a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units. The sale does not represent a discretionary trade by the reporting person.